Avalere Health

Meeting people where they are in the digital world can have profound outcomes for the success of your vaccine. Get more advice on how you can reach diverse communities in our latest article from strategy experts Kathryn Stewart and Alex Hope, and get in touch to learn how Avalere Health can support you in building customized marketing solutions to bring your vaccine product to the people who need it most: https://bit.ly/3ONiiDH #WeAreAvalereHealth #Vaccines #HealthcareMarketing #VaccinesStrategy

Vaccine hesitancy costs lives. Public health, the economy, and our communities are impacted when take-up is below herd immunity levels. Our experts in storytelling, behavioral science and medical communications unpack their advice on ensuring every person is supported to make informed decisions. Learn more in our latest article from our strategy experts Kathryn Stewart and Alex Hope: https://bit.ly/3ONiiDH #WeAreAvalereHealth #Vaccines #HealthcareMarketing #BehavioralScience #VaccineHesitancy

In conversation with PM360 Magazine, our experts Ify Jikeme Francis, MS, PMP and Darlene Doubert shared their insights on keeping up with the fast-paced payer strategy landscape.  Click through to PM360 Magazine to gain a deeper understanding of: ✏️ Emerging trends in payer strategies, including increased demands for real-world evidence and the growing importance of health equity ✏️ The influence of AI on payer strategies, and how it can enable faster, more efficient, and more personalized care  Read more: https://lnkd.in/g4SmFGaV #WeAreAvalereHealth #PayerStrategies #ArtificialIntelligence 

For the greatest impact, differentiate beyond the science. Several factors come together to drive the best decisions about vaccination, including: ✏️ Storage and reconstitution requirements ✏️ The number of visits needed to complete the schedule ✏️ How well HCPs and patients understand and engage with the product For more insights, get in touch today and learn how we can support you to reach every person: https://bit.ly/3AMueCh #WeAreAvalereHealth #Vaccines #VaccinesStrategy

📣 Our Graduate Program is open for applications! 📣 Offering 18 months of placements across our business, the program is designed to enable cross-functional collaboration between our graduates, mentors, capabilities, and clients. We caught up with our current cohort to gain their perspectives on how they've benefitted from our Graduate Program's rotational structure. Learn more and apply for 2025 entry here: https://bit.ly/3Yk5REH #AvalereHealth #GraduateProgram #EarlyCareers #CareerDevelopment #WeAreAvalereHealth

It’s the final day of #ISPOREU2024! Are you ready to practically apply the insights learned to reach more patients? There’s still time to connect with our experts. Schedule your meeting today at ISPOREUMeeting@avalerehealth.com, or stop by Booth #1412 to meet the team! #ISPOREurope #ISPOR #WeAreAvalereHealth

Today’s the day! Our very own Laura T. Housman, MPH, MBA, DrPH(c) is hosting our panel discussion at 11.45am on 'The Application of Indirect Burden of Disease Evidence in US Value Assessment and Ex-US HTA Submissions’ at #ISPOREU2024, with insights from Karl-Johan Myren (Alexion Pharmaceuticals, Inc.), and our experts, Taylor Schwartz, and Jan McKendrick. Join the team in room 211, level P2, to learn more about the indirect costs of patient care and their significance for value assessment and ex-US HTA submissions. Schedule your meeting with the team today at ISPOREUMeeting@avalerehealth.com #ISPOREurope #ISPOR #ValueAssessment #PatientCare #Patients #HTA #WeAreAvalereHealth

Thank you Med Ad News for featuring our own Sarah Alwardt in the upcoming Healthcare Agency Roundtable! Read the full article to discover more of Sarah’s insights on how the outcome of the 2024 US election will impact healthcare. Learn more: https://lnkd.in/exhhrSz5 #Election2024 #HealthPolicy #WeAreAvalereHealth

Our #ISPOREU2024 panel is tomorrow! Join us for 'The Application of Indirect Burden of Disease Evidence in US Value Assessment and Ex-US HTA Submissions,’ where our own Laura T. Housman, MPH, MBA, DrPH(c) will be in conversation with Karl-Johan Myren of Alexion Pharmaceuticals, Inc., and our experts Taylor Schwartz and Jan McKendrick. Join us at 11:45am in room 211, level P2, for unmissable insights on the changing landscape. #ISPOREurope #ISPOR #ValueAssessment #PatientCare #Patients #HTA #WeAreAvalereHealth

Are you attending #ISPOREU2024? Join us for at Booth #1412 at 6pm tonight for a drinks reception and opportunity to catch up on the first day of action. Schedule your meeting with us at ISPOR today: ISPOREUMeeting@avalerehealth.com #ISPOREurope #ISPOR #MarketAccess #ValueAssessment #PatientCare #WeAreAvalereHealth